{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:17:38Z","timestamp":1763018258384,"version":"3.41.2"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Gilead Pharmaceuticals","award":["IN-US-342\u20134420"],"award-info":[{"award-number":["IN-US-342\u20134420"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Rates of hepatitis C virus (HCV) among women of childbearing age have increased as a result of the opioid epidemic, especially in the nonurban white population. Recently updated US Preventative Services Task Force and Centers for Disease Control and Prevention guidance have recommended universal HCV screening during pregnancy, but obstetrics societies have not yet endorsed this recommendation. We evaluated the seroprevalence of HCV among pregnant women in an inner-city population, compared rates with other sexually transmitted infections (STIs) screened for during pregnancy, and evaluated factors associated with HCV positivity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a prospective seroprevalence study of consecutive labor and delivery admissions (both antepartum complications and delivery admissions) by testing serum samples for HCV antibody over 9 months at 2 major hospital settings in New York City.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Fifty-six of 7373 (0.75%; 95% confidence interval [CI], 0.57\u20130.98) patients screened positive for HCV, with 28 of 4013 (0.70%; 95% CI, 0.46%\u20131.01%) and 28 of 3413 (0.82%; 95% CI, 0.55%\u20131.18%) at each hospital. Forty-one percent of HCV-positive patients had any reported HCV risk factors. Hepatitis C virus-positive patients were less likely to have private insurance and more likely to have a history of cannabis, cocaine, and injection drug use (P\u2005&amp;lt;\u2005.001). The HCV rates were higher among antepartum admissions compared with delivery admissions and higher than that of hepatitis B virus (0.65%; 95% CI, 0.48\u20130.86), human immunodeficiency virus (0.27%; 95% CI, 0.16\u20130.42), and syphilis (0.16%; 95% CI, 0.08\u20130.28).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We found a higher than expected HCV seroprevalence among pregnant women and higher than most other STIs routinely screened for in pregnancy. Most patients had no risk factors. These findings support universal screening for hepatitis C during pregnancy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaa514","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T17:15:05Z","timestamp":1603473305000},"source":"Crossref","is-referenced-by-count":7,"title":["Hepatitis C Seroprevalence Among Consecutive Labor and Delivery Admissions in Two New York City Hospitals"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6663-6253","authenticated-orcid":false,"given":"Tatyana","family":"Kushner","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA"},{"name":"Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Masand","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Wagner","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology and Reproductive Science, Division of Maternal Fetal Medicine, Mount Sinai West, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Grace","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Icahn School of Medicine at Mount Sinai"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Rosenbluth","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA"},{"name":"Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Rodriguez-Rivas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA"},{"name":"Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hernis","family":"de la Cruz","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Center for Biostatistics, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Overbey","sequence":"additional","affiliation":[{"name":"Department of Population Health Science and Policy, Center for Biostatistics, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhoda","family":"Sperling","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA"},{"name":"Department of Obstetrics, Gynecology and Reproductive Science and the Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"2021062903024127300_CIT0001","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014","volume":"108","author":"Zibbell","year":"2018","journal-title":"Am J Public Health"},{"author":"Communicable disease in New York State exclusive of New York City Rate Per 100,000 of Cases Reported 2009-2018","key":"2021062903024127300_CIT0002"},{"key":"2021062903024127300_CIT0003","doi-asserted-by":"crossref","first-page":"775","DOI":"10.7326\/M16-2350","article-title":"Hepatitis C virus infection among reproductive-aged women and children in the United States, 2006 to 2014","volume":"166","author":"Ly","year":"2017","journal-title":"Ann Intern Med"},{"key":"2021062903024127300_CIT0004","doi-asserted-by":"crossref","first-page":"470","DOI":"10.15585\/mmwr.mm6618a3","article-title":"Hepatitis C virus infection among women giving birth\u2014Tennessee and United States, 2009-2014","volume":"66","author":"Patrick","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021062903024127300_CIT0005","doi-asserted-by":"crossref","first-page":"705","DOI":"10.15585\/mmwr.mm6528a2","article-title":"Increased hepatitis C virus (HCV) detection in women of childbearing age and potential risk for vertical transmission\u2014United States and Kentucky, 2011-2014","volume":"65","author":"Koneru","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021062903024127300_CIT0006","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.amepre.2018.05.029","article-title":"Hepatitis C virus in women of childbearing age, pregnant women, and children","volume":"55","author":"Schillie","year":"2018","journal-title":"Am J Prev Med"},{"key":"2021062903024127300_CIT0007","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jama.2020.1123","article-title":"Screening for hepatitis C virus infection in adolescents and adults: US preventive services task force recommendation statement","volume":"323","author":"US Preventive Services Task Force","year":"2020","journal-title":"JAMA"},{"key":"2021062903024127300_CIT0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults\u2014United States, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"2021062903024127300_CIT0009","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: systematic review and meta-analysis","volume":"59","author":"Benova","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021062903024127300_CIT0010","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2017.07.039","article-title":"Hepatitis C in pregnancy: screening, treatment, and management","volume":"217","author":"Society for Maternal-Fetal Medicine","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2021062903024127300_CIT0011","doi-asserted-by":"crossref","first-page":"38.e1","DOI":"10.1016\/j.ajog.2008.03.052","article-title":"Pregnancy complications associated with hepatitis C: data from a 2003\u20132005 Washington state birth cohort","volume":"199","author":"Pergam","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2021062903024127300_CIT0012","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1111\/j.1365-2893.2011.01436.x","article-title":"Pregnancy outcomes associated with viral hepatitis","volume":"18","author":"Reddick","year":"2011","journal-title":"J Viral Hepat"},{"volume-title":"Recommendations for testing, managing, and treating hepatitis C","author":"AASLD-IDSA","key":"2021062903024127300_CIT0013"},{"key":"2021062903024127300_CIT0014","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S2666-5247(20)30062-8","article-title":"Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study","volume":"1","author":"Chappell","year":"2020","journal-title":"Lancet Microbe"},{"author":"Centers for Disease Control and Preventin","key":"2021062903024127300_CIT0015","article-title":"Guidance on Hepatitis C."},{"key":"2021062903024127300_CIT0016","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/cid\/ciu643","article-title":"Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012","volume":"59","author":"Suryaprasad","year":"2014","journal-title":"Clin Infect Dis"},{"article-title":"Newborn testing reveals high HCV seroprevalence in pregnant women from New York State","year":"2020","author":"Styer","key":"2021062903024127300_CIT0017"},{"key":"2021062903024127300_CIT0018","doi-asserted-by":"crossref","first-page":"833","DOI":"10.15585\/mmwr.mm6839a1","article-title":"National trends in hepatitis C infection by opioid use disorder status among pregnant women at delivery hospitalization\u2014United States, 2000\u20132015","volume":"68","author":"Ko","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021062903024127300_CIT0019","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/AOG.0000000000003754","article-title":"Hepatitis C virus antibody screening in a cohort of pregnant women: identifying seroprevalence and risk factors","volume":"135","author":"Prasad","year":"2020","journal-title":"Obstet Gynecol"},{"key":"2021062903024127300_CIT0020","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/hep.26245","article-title":"Association of tattooing and hepatitis C virus infection: a multicenter case-control study","volume":"57","author":"Carney","year":"2013","journal-title":"Hepatology"},{"key":"2021062903024127300_CIT0021","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.30297","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016","volume":"69","author":"Hofmeister","year":"2019","journal-title":"Hepatology"},{"key":"2021062903024127300_CIT0022","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/AOG.0000000000002807","article-title":"Prevalence of maternal hepatitis C virus infection in Ohio","volume":"132","author":"Rossi","year":"2018","journal-title":"Obstet Gynecol"},{"author":"Centers for Disease Control and Prevention","key":"2021062903024127300_CIT0023","article-title":"Surveillance for Viral Hepatitis - United States, 2017"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaa514\/33999215\/ofaa514.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/11\/ofaa514\/38835213\/ofaa514.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/11\/ofaa514\/38835213\/ofaa514.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T03:03:10Z","timestamp":1624935790000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaa514\/5936963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaa514","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,10,23]]},"article-number":"ofaa514"}}